Stay updated on THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Sign up to get notified when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.
Latest updates to the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page
- Check14 days agoChange DetectedThe page has undergone significant content removal, including the deletion of a detailed study description and inclusion/exclusion criteria for a clinical trial related to acute ischaemic stroke and transient ischaemic attack. A new revision number has been added, indicating an update to the document.SummaryDifference0.2%
- Check121 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check143 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check150 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference1%
- Check165 days agoChange DetectedThe website has been updated from version v2.12.1 to v2.12.2.SummaryDifference0.0%
- Check186 days agoChange DetectedThe website has been updated from version v2.11.2 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.